[1] |
GIBSON C M, PRIDE Y B, HOCHBERG C P, et al. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome:PCI-PROVE IT:A PROVE IT-TIMI 22(pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22) substudy[J]. J Am Coll Cardiol, 2009, 54(24):2290-2295.
DOI
URL
|
[2] |
YAN A T, YAN R T, TAN M, et al. Risk scores for risk stratification in acute coronary syndromes:useful but simpler is not necessarily better[J]. Eur Heart J, 2007, 28(9):1072-1078.
DOI
URL
|
[3] |
FOX K A, GOODMAN S G, KLEIN W, et al. Management of acute coronary syndromes. Variations in practice and outcome;findings from the Global Registry of Acute Coronary Events(GRACE)[J]. Eur Heart J, 2002, 23(15):1177-1189.
DOI
URL
|
[4] |
PEARSON I R, VISWANATHAN K, KILCULLEN N, et al. Cardiac morbidity and mortality can be accurately predicted in patients presenting with ACS using multiple biomarkers measured on an admission blood sample[J]. Heart, 2011, 97(Suppl 1):A8.
|
[5] |
STORROW A B, APPLE F S, WU A H B, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines:point of care testing,oversight,and administration of cardiac biomarkers for acute coronary syndromes[J]. Point of Care, 2007, 6(4):215-222.
DOI
URL
|
[6] |
SHIMPO M, MORROW D A, WEINBERG E O . Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction[J]. Circulation, 2004, 109(18):2186-2190.
DOI
URL
|
[7] |
DEMYANETS S, KAUN C, PENTZ R, et al. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature[J]. J Mol Cell Cardiol, 2013, 60:16-26.
DOI
URL
|
[8] |
BRAUNWALD E, ANTMAN E M, BEASLEY J W, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article:a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients with Unstable Angina)[J]. J Am Coll Cardiol, 2002, 40(7):1366-1374.
DOI
URL
|
[9] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J]. 中华心血管病杂志, 2017, 45(5):359-376.
|
[10] |
PICKERING J W, GREENSLADE J H, CULLEN L, et al. Assessment of the European Society of Cardiology 0-hour/1-hour algorithm to rule-out and rule-in acute myocardial infarction[J]. Circulation, 2016, 134(20):1532-1541.
DOI
URL
|
[11] |
APPLE F S, SANDOVAL Y, JAFFE A S, et al. Cardiac troponin assays:guide to understanding analytical characteristics and their impact on clinical care[J]. Clin Chem, 2017, 63(1):73-81.
DOI
URL
|
[12] |
Writing Committee for the VISION Study Investigators, DEVEREAUX P J, BICCARD B M, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery[J]. JAMA, 2017, 317(16):1642-1651.
DOI
URL
|
[13] |
JENKINS W S, ROGER V L, JAFFE A S, et al. Prognostic value of soluble ST2 after myocardial infarction:a community perspective[J]. Am J Med, 2017, 130(9):1112.e9-1112.e15.
DOI
URL
|
[14] |
SCHMITZ J, OWYANG A, OLDHAM E, et al. IL-33,an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity, 2005, 23(5):479-490.
DOI
URL
|
[15] |
SHETELIG C, UELAND T, LIMALANATHAN S, et al. Circulating levels of ST2 are associated with myocardial injury,left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction[J]. Eur Heart J, 2019, 40(Suppl 1):1303.
DOI
URL
|